Sign In
Buy BLUE
$4.97
+0 (+0%)
At Close: Aug 29, 2025
BMS and bluebird bio Announce Submission of Biologics License Application (BLA) to FDA for Idecabtagene Vicleucel (Ide-cel, bb2121)...
Gene Therapy Companies Are Racing to Cure Sickle Cell. That Would Open the Door to Curing Dozens of Other Diseases.
03:52pm, Saturday, 25'th Jul 2020
Successful treatments would demonstrate the potential for gene therapy—and boost a number of biotech companies.
Were Hedge Funds Right About bluebird bio Inc (BLUE)?
05:41pm, Monday, 13'th Jul 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
How Much Of bluebird bio, Inc. (NASDAQ:BLUE) Do Institutions Own?
04:08pm, Tuesday, 07'th Jul 2020
The big shareholder groups in bluebird bio, Inc. (NASDAQ:BLUE) have power over the company. Insiders often own a large...
Rexgenero Appoints Dr Gilbert Wagener as Senior Vice President and Chief Medical Officer
12:00am, Thursday, 02'nd Jul 2020
Rexgenero, a regenerative medicine company appoints Dr Gilbert Wagener as Senior Vice President and Chief Medical Officer.
Wall Street Has Given Up on These 2 Stocks, and That's a Huge Mistake
12:31pm, Wednesday, 01'st Jul 2020
For instance, Shopify (NYSE: SHOP) has been an expensive stock for years. StoneCo (NASDAQ: STNE) has unbelievably good numbers. In my mind, StoneCo is very similar to Square (NYSE: SQ), the fintech
2 Top Gene-Editing Stocks to Buy Right Now | The Motley Fool
11:36am, Sunday, 28'th Jun 2020
Both of these biotech companies recently released encouraging data from clinical trials.
Two Sigma Advisers LP Decreases Holdings in bluebird bio Inc (NASDAQ:BLUE)
06:49am, Thursday, 25'th Jun 2020
Two Sigma Advisers LP trimmed its holdings in shares of bluebird bio Inc (NASDAQ:BLUE) by 0.4% in the first quarter, Holdings Channel reports. The firm owned 112,100 shares of the biotechnology compan
Global CAR T Cell Therapy Market to 2026 - by Regions, Targeted Antigens, Clinical Trials/Study & Companies - ResearchAndMarkets.com
12:00am, Wednesday, 24'th Jun 2020
The
How bluebird bio (BLUE) Stock Stands Out in a Strong Industry
12:39pm, Tuesday, 23'rd Jun 2020
bluebird bio (BLUE) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Repare and Forma Shares Gobbled Up in IPO
08:35pm, Monday, 22'nd Jun 2020
Both companies boosted price and number of shares in their offerings Continue reading...
Cardiff City's Jazz Richards announces he's left the club after latest injury
06:09pm, Saturday, 20'th Jun 2020
The defender has endured his fair share of lay-offs through injury
bluebird On The Go, And Other News: The Good, Bad And Ugly Of Biopharma
09:02pm, Wednesday, 17'th Jun 2020
bluebird reports multiple positive trial data. BeiGene's blood cancer trial reports positive data. TG Therapeutics' TG-1701 reports positive interim data.
Appellate Judges Rule HHS Doesn’t Have Authority To Require Prices In TV Ads For Drugs
11:52am, Tuesday, 16'th Jun 2020
Read about the biggest pharmaceutical development and pricing stories from the past week in KHN’s Prescription Drug Watch roundup.
Bluebird and Crispr Show Promise for Sickle-Cell Cures
10:30am, Tuesday, 16'th Jun 2020
The new data on Crispr’s products prompts Canaccord Genuity analyst to raise her price target on the Buy-rated stock.
